• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer

    4/23/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $TLRY alert in real time by email

    COLUMBUS, Ohio, April 23, 2026 (GLOBE NEWSWIRE) -- BrewDog USA by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), today unveiled its lineup of headliner products and bold innovation bets for spring and summer, signaling a renewed focus on flavor, disruption, and momentum across craft beer and emerging beverage categories in the U.S. With the strength of its core brands and the backing of Tilray Brands, BrewDog USA is accelerating an innovation-led growth strategy built around standout products designed to win with today's modern drinker.

    At the center of the lineup is Elvis Juice, BrewDog's signature citrus IPA. At 6.5% ABV and available in multiple formats including 6-packs, 12-packs, 19.2 oz cans, and draft, Elvis Juice continues to define the brand's bold flavor profile. This summer, BrewDog is amplifying the brand with its "Juiced Up. Lifted Up." campaign, giving fans the chance to win helicopter rides across major U.S. cities. The campaign taps into BrewDog's rebellious DNA while reinforcing Elvis Juice as a high-impact, refreshingly bold IPA built to stand out.

    BrewDog is also expanding its reach beyond traditional beer with the launch of Juice Club, a new non-alcoholic lineup crafted for full flavor without compromise. Available in four distinct expressions - Citrus Crush, Raspberry Tart, Key Lime Pils, and Pineapple Breeze - Juice Club delivers variety, versatility, and a premium taste experience in one of the fastest-growing segments in beverage.

    Brittany Foster, Head of Brand & Marketing, BrewDog USA, stated, "We lead with quality and flavor - always. That's been at the core of BrewDog from day one. As we enter this next phase, we're accelerating innovation and pushing the boundaries of what beer and beyond beer - can be. Our focus is simple: deliver bold, differentiated products that create energy on shelves and behind the bar and give consumers more reasons to choose BrewDog every time."

    Hazy Jane continues to gain momentum as BrewDog USA's #2 brand by volume, offering a smooth, fruit-forward New England–style IPA at 7.2% ABV. Its approachable, juicy profile has made it a go-to for hazy IPA drinkers nationwide. Building on that success, BrewDog introduced Baby Hazy, a 3.2% ABV lower-alcohol option designed for the fast-growing moderation occasion—delivering the same tropical character in a lighter, more sessionable format.

    The portfolio is further strengthened by BrewDog IPA, a modern take on the classic that brings the brand back to its roots—bold, conversation-starting, and uncompromising. This summer, BrewDog will donate a portion of BrewDog IPA sales to Gigi's, a Columbus-based organization providing shelter, veterinary care, behavioral support, and adoption services for homeless dogs—reinforcing the brand's commitment to community impact.

    Additional fan favorites include 95, a 95-calorie tropical session IPA built for active, balanced lifestyles, and Cold Beer, a crisp, easy-drinking lager designed for everyday occasions.

    Fueling what's next, BrewDog continues to push boundaries through its Columbus-based pilot brewery, accelerating new product development and bringing fresh ideas to market with speed and creativity.

    From iconic headliners to next-generation innovation, BrewDog USA is entering the season with momentum and a clear ambition to lead from the front.

    Consumers can explore the full portfolio online and experience BrewDog firsthand at locations across the country.

    For more information, visit https://usa.brewdog.com/ or follow @BrewDogUSA on social media.

    About BrewDog USA

    BrewDog USA is a leading craft brewery known for bold flavor, quality brewing, and a relentless focus on innovation across beer and non-alcoholic offerings. With a portfolio that spans iconic headliners like Elvis Juice, Hazy Jane, BrewDog IPA, Cold Beer, and 95 to new innovations like Juice Club, BrewDog continues to push the boundaries of what beer can be. The brand distributes across 15 states; Ohio, Michigan, Kentucky, Indiana, Illinois, Wisconsin, Pennsylvania, New Jersey, New York, Virginia, Georgia, Florida, Colorado, Nevada, and California, and operates a growing network of retail bar restaurants and destinations. These include its flagship campus in Canal Winchester, Ohio, home to DogTap Brewery and the 34-room DogHouse Hotel, as well as locations in New Albany and Cleveland, a franchise location in Denver, and a Las Vegas Strip rooftop bar, all designed to bring the BrewDog experience to life.

    About Tilray Brands

    Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment elevating lives through moments of connection. Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray's unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods and craft beverages. 

    For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms. 

    Forward-Looking Statements

    Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, "forward-looking statements") under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the "safe harbor" created by those sections and other applicable laws. Forward-looking statements can be identified by words such as "forecast," "future," "should," "could," "enable," "potential," "contemplate," "believe," "anticipate," "estimate," "plan," "expect," "intend," "may," "project," "will," "would" and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.  

    Contacts:

    Media 

    [email protected]

    Investor Relations 

    [email protected]

    Photos accompanying this announcement are available at:

    https://www.globenewswire.com/NewsRoom/AttachmentNg/d423c9fd-1d8f-4ea0-bf36-4f5c40fa13e7

    https://www.globenewswire.com/NewsRoom/AttachmentNg/43a995fa-dca7-4880-976b-b76d60945fbe

    https://www.globenewswire.com/NewsRoom/AttachmentNg/b17e983a-e585-467f-bd9b-4fd5764a56eb

    https://www.globenewswire.com/NewsRoom/AttachmentNg/ea29144f-6779-47d6-bbf7-fb9177b30e37



    Primary Logo

    Get the next $TLRY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TLRY

    DatePrice TargetRatingAnalyst
    4/3/2026$10.00Neutral → Buy
    Roth Capital
    4/2/2026$10.00Neutral → Buy
    Roth Capital
    1/27/2026Hold
    Canaccord Genuity
    4/5/2024$2.25 → $2.75Neutral
    Alliance Global Partners
    11/2/2022$3.90Mkt Perform
    Bernstein
    7/29/2022$3.00Hold → Sell
    The Benchmark Company
    3/4/2022$9.00Hold → Buy
    Canaccord Genuity
    1/11/2022$7.40 → $6.90Neutral
    Cantor Fitzgerald
    More analyst ratings

    $TLRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hopkinson David G.

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    4/22/26 5:30:45 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Cohen Steven Michael exercised 12,438 shares at a strike of $8.99 (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    1/8/26 4:24:12 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    President and CEO Simon Irwin D exercised 706,216 shares at a strike of $0.58 and covered exercise/tax liability with 374,295 shares, increasing direct ownership by 7% to 4,826,493 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:07:08 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    SEC Filings

    View All

    Tilray Brands Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Tilray Brands, Inc. (0001731348) (Filer)

    4/21/26 4:40:40 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 424B7 filed by Tilray Brands Inc.

    424B7 - Tilray Brands, Inc. (0001731348) (Filer)

    4/21/26 4:36:00 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 424B5 filed by Tilray Brands Inc.

    424B5 - Tilray Brands, Inc. (0001731348) (Filer)

    4/15/26 9:13:28 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/3/26 10:44:58 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray upgraded by Roth Capital with a new price target

    Roth Capital upgraded Tilray from Neutral to Buy and set a new price target of $10.00

    4/2/26 7:55:13 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Canaccord Genuity initiated coverage on Tilray

    Canaccord Genuity initiated coverage of Tilray with a rating of Hold

    1/27/26 9:29:20 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling

    NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today issued a statement applauding President Donald Trump's actions leading to rescheduling of cannabis from Schedule I to Schedule III under the Controlled Substances Act - a defining inflection point that represents a fundamental shift in U.S. drug policy, unlocking significant opportunities for medical cannabis clinical research, patient access, and industry standardization. The action represents the most consequential federal cannabis

    4/23/26 8:53:52 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer

    COLUMBUS, Ohio, April 23, 2026 (GLOBE NEWSWIRE) -- BrewDog USA by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), today unveiled its lineup of headliner products and bold innovation bets for spring and summer, signaling a renewed focus on flavor, disruption, and momentum across craft beer and emerging beverage categories in the U.S. With the strength of its core brands and the backing of Tilray Brands, BrewDog USA is accelerating an innovation-led growth strategy built around standout products designed to win with today's modern drinker. At the center of the lineup is Elvis Juice, BrewDog's signature citrus IPA. At 6.5% ABV and available in multiple formats including 6-packs, 12-packs, 19.2

    4/23/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care

    NEW YORK and LEAMINGTON, Ontario, April 20, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage, and wellness industries, today marked 4/20 by reinforcing its leadership in medical cannabis and its commitment to advancing patient care through a science-driven global platform. Irwin D. Simon, Chairman and Chief Executive Officer, stated: "4/20 reflects how far this industry has evolved, from an emerging category into a global opportunity grounded in science, innovation, and patient impact. At Tilray, we've built a diversified international platfor

    4/20/26 9:56:27 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Global General Counsel Gendel Mitchell exercised 93,928 shares at a strike of $0.58, covered exercise/tax liability with 49,782 shares and bought $3,496 worth of shares (6,000 units at $0.58), increasing direct ownership by 8% to 698,287 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:19 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    President and CEO Simon Irwin D bought $100,106 worth of shares (165,000 units at $0.61), increasing direct ownership by 4% to 3,941,633 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 6:52:32 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Financial Officer Merton Carl A bought $19,939 worth of shares (33,500 units at $0.60), increasing direct ownership by 4% to 798,069 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 3:12:46 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    Leadership Updates

    Live Leadership Updates

    View All

    Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois

    BRECKENRIDGE, Colo., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand owned by Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), has announced appointment of Romano Beverage, a respected partner, to manage distribution responsibilities within the state. Romano Beverage, a trusted leader in beverage distribution, is now overseeing Breckenridge Distillery's full spirits collection across Illinois—including its celebrated bourbon whiskey, whiskey, rum, vodka, gin, and newly launched Mountain Shot. Romano's strong presence in Illinois and dedication to exceptional service make them the perfect partner to help Breckenridge Distillery thr

    2/4/26 8:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Terrapin Beer Co. Celebrates 20 Years of Iconic Wake-n-Bake Beer with Exciting Wake-n-Bake Off Event in Athens, GA

    ATHENS, Ga., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Terrapin Beer Co., a Tilray Beverages craft beer brand under Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), is excited to announce the 20th anniversary of its Wake-n-Bake Coffee Oatmeal Imperial Stout seasonal beer and the annual Wake-n-Bake Off event on Sunday, January 26th, 2025, at the Terrapin taproom in Athens, GA. In celebration of its 20th anniversary, guests will have the chance to observe local restaurants competing to craft the finest dish featuring Terrapin's renowned Wake-n-Bake Beer. This event highlights culinary innovation and fosters community engagement through an array of sweet and savory tastings that showcase the rich flavor

    1/23/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Blue Point Brewing Launches Big Mo Brew to Raise Funds and Awareness for Men's Health During Movember

    PATCHOGUE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Blue Point Brewing Company, Long Island's original craft brewery and subsidiary of Tilray Brands, (NASDAQ:TLRY, TSX:TLRY), is proud to announce the continuation of its men's health awareness campaign in support of Movember. The month shines a light on key men's health issues—mental health, prostate cancer, and testicular cancer—encouraging open conversations and proactive engagement. To honor the initiative, Blue Point Brewing announced the special release of its classic double IPA, Big Mo, available at our brewery and retailers in Long Island, New York. This hazy double IPA, featuring prominent mosaic hops and an ABV of 8.0%, proud

    10/22/24 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    Financials

    Live finance-specific insights

    View All

    Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026

    NEW YORK and LEAMINGTON, Ontario, March 25, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the third fiscal quarter which ended February 28, 2026, before the financial markets open on Wednesday, April 1, 2026. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 AM Eastern Time on the same day. The webcast can be accessed on the Events & Presentations section of Ti

    3/25/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region

    Acquisition Includes BrewDog's Profitable Australian Operations Including Brisbane Brewery and Two Flagship Bars Transaction Positions Tilray to Scale BrewDog Across Australia's National Retail and Grocery Channels and Introduce Broader Beverage Portfolio Across Asia-Pacific NEW YORK and BRISBANE, Australia, March 09, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced the completion of the acquisition of BrewDog Brewing Australia Pty Ltd., including BrewDog's Australian brewing and pr

    3/9/26 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform

    Accretive Acquisition of Select Assets Includes Global Brand, UK Brewing Operations and 11 Strategic Brewpubs  Expected to Generate ~$200 Million in Annual Net Revenue and ~$6 - $8 Million of Adjusted EBITDA in Fiscal 2027 Tilray's Global Consolidated Net Revenue Expected to Reach ~$1.2 Billion on an Annualized Basis1 Conference Call Scheduled for 12:30pm ET NEW YORK and LONDON, March 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray", "our", "we" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today completed the acquisition of certain highly strategic

    3/2/26 10:17:01 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Tilray Brands Inc. (Amendment)

    SC 13G/A - Tilray Brands, Inc. (0001731348) (Subject)

    2/13/23 1:34:44 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Tilray Brands Inc.

    SC 13G - Tilray Brands, Inc. (0001731348) (Subject)

    2/10/23 4:41:36 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13D filed by Tilray Brands Inc.

    SC 13D - Tilray Brands, Inc. (0001731348) (Filed by)

    7/22/22 4:30:22 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care